BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rees JD, Lança S, Marques PV, Gómez-Puerta JA, Moco R, Oliveri C, Khamashta MA, Hughes GR, D'Cruz DP. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis 2006;65:109-11. [PMID: 16344494 DOI: 10.1136/ard.2004.034231] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Lee YM, Lee MW, Lee YH, Baek S. Bilateral Frosted Branch Angiitis in Anti-phospholipid Antibody Syndrome. J Korean Ophthalmol Soc 2022;63:630-636. [DOI: 10.3341/jkos.2022.63.7.630] [Reference Citation Analysis]
2 Yeo J, Hwang I, Sohn C, Lee EE, Lee S, Lee EB, Park JK. Proliferative Vasculopathy Associated With Antiphospholipid Antibodies in Patients With Neurological Symptoms. Front Med 2022;9:913203. [DOI: 10.3389/fmed.2022.913203] [Reference Citation Analysis]
3 Akhlaghi Kalahroodi M, Loghman M, Ramezanpoor M, Shahriarirad R, Rahmanian E. Antineutrophil cytoplasmic antibody-associated vasculitis in presence of positive antiphospholipid antibody: a case report. J Med Case Reports 2022;16. [DOI: 10.1186/s13256-022-03256-3] [Reference Citation Analysis]
4 Chae HJ, Kim JW, Lee YL, Park JH, Lee SY. Mononeuropathy multiplex associated with systemic vasculitis: A case report. World J Clin Cases 2021; 9(7): 1741-1747 [PMID: 33728320 DOI: 10.12998/wjcc.v9.i7.1741] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Claudel SE, Tucker BM, Kleven DT, Pirkle JL Jr, Murea M. Narrative Review of Hypercoagulability in Small-Vessel Vasculitis. Kidney Int Rep 2020;5:586-99. [PMID: 32405580 DOI: 10.1016/j.ekir.2019.12.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ahluwalia J, Sharma S. Laboratory Testing for the Antiphospholipid Syndrome. Women's Health in Autoimmune Diseases 2020. [DOI: 10.1007/978-981-15-0114-2_5] [Reference Citation Analysis]
7 Zhang Y, Riddle ND, Seminario-vidal L. Post-partum cutaneous manifestation of antiphospholipid syndrome. Human Pathology: Case Reports 2019;18:200334. [DOI: 10.1016/j.ehpc.2019.200334] [Reference Citation Analysis]
8 Leaver PJ, Jang HS, Wong MG, Soh HC, Fernando SL. ANCA-associated vasculitis of the appendix. Rheumatol Adv Pract 2019;3:rkz037. [PMID: 31650102 DOI: 10.1093/rap/rkz037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 López-villegas VJ, Medina-morales DA, Saldarriaga-rivera LM. Poliangitis microscópica y síndrome antifosfolípido. Una asociación infrecuente. Revista Colombiana de Reumatología 2019;26:287-291. [DOI: 10.1016/j.rcreu.2018.08.001] [Reference Citation Analysis]
10 López-villegas VJ, Medina-morales DA, Saldarriaga-rivera LM. Microscopic polyangiitis and antiphospholipid syndrome. An uncommon association. Revista Colombiana de Reumatología (English Edition) 2019;26:285-289. [DOI: 10.1016/j.rcreue.2018.08.004] [Reference Citation Analysis]
11 Caprio FZ, Lin C. Unusual causes of ischemic stroke and transient ischemic attack. Warlow's Stroke 2019. [DOI: 10.1002/9781118492390.ch7] [Reference Citation Analysis]
12 Vece TJ, De Guzman MM, Langston C, Fan LL. Diffuse Alveolar Hemorrhage in Children. Kendig's Disorders of the Respiratory Tract in Children 2019. [DOI: 10.1016/b978-0-323-44887-1.00061-4] [Reference Citation Analysis]
13 Siddique S, Risse J, Canaud G, Zuily S. Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy? Curr Rheumatol Rep 2017;19:64. [PMID: 28871481 DOI: 10.1007/s11926-017-0687-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
14 Jordan N, D'cruz DP. Association of Lupus Anticoagulant With Long-Term Damage Accrual in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken) 2016;68:711-5. [PMID: 26415137 DOI: 10.1002/acr.22723] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
15 D'Agostino C, Zonzin P, Enea I, Gulizia MM, Ageno W, Agostoni P, Azzarito M, Becattini C, Bongarzoni A, Bux F, Casazza F, Corrieri N, D'Alto M, D'Amato N, D'Armini AM, De Natale MG, Di Minno G, Favretto G, Filippi L, Grazioli V, Palareti G, Pesavento R, Roncon L, Scelsi L, Tufano A. ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism. Eur Heart J Suppl 2017;19:D309-32. [PMID: 28751848 DOI: 10.1093/eurheartj/sux030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
16 Levy RA, Gómez-puerta JA, Cervera R. History, Classification, and Subsets of the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2017. [DOI: 10.1016/b978-0-444-63655-3.00001-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Kwok S, Seo S, Ju J, Park K, Yoon C, Kim W, Min J, Park S, Cho C, Kim H. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus 2007;16:803-9. [DOI: 10.1177/0961203307082383] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
18 Chan E, Sangle SR, Coghlan JG, D'Cruz DD. Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature. Autoimmun Rev 2016;15:375-8. [PMID: 26777307 DOI: 10.1016/j.autrev.2016.01.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
19 Siddique F, Patel DP, Roberts WN. Antiphospholipid Syndrome. Compendium of Inflammatory Diseases 2016. [DOI: 10.1007/978-3-7643-8550-7_161] [Reference Citation Analysis]
20 Lally L, Sammaritano LR. Vasculitis in Antiphospholipid Syndrome. Rheumatic Disease Clinics of North America 2015;41:109-23. [DOI: 10.1016/j.rdc.2014.09.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
21 Siddique F, Patel DP, Roberts WN. Antiphospholipid Syndrome. Encyclopedia of Inflammatory Diseases 2015. [DOI: 10.1007/978-3-0348-0620-6_161-6] [Reference Citation Analysis]
22 Salmela A, Ekstrand A, Joutsi-korhonen L, Räisänen-sokolowski A, Lassila R. Activation of endothelium, coagulation and fibrinolysis is enhanced and associates with renal anti-neutrophil cytoplasmic antibody-associated vasculitis†. Nephrology Dialysis Transplantation 2015;30:i53-9. [DOI: 10.1093/ndt/gfu379] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
23 Jordan NP, Bezanahary H, D'Cruz DP. Increased risk of vascular complications in Takayasu's arteritis patients with positive lupus anticoagulant. Scand J Rheumatol 2015;44:211-4. [PMID: 25438797 DOI: 10.3109/03009742.2014.964305] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
24 Franco JS, Molano-González N, Rodríguez-Jiménez M, Acosta-Ampudia Y, Mantilla RD, Amaya-Amaya J, Rojas-Villarraga A, Anaya JM. The coexistence of antiphospholipid syndrome and systemic lupus erythematosus in Colombians. PLoS One 2014;9:e110242. [PMID: 25343509 DOI: 10.1371/journal.pone.0110242] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
25 Jordan NP, Verma H, Siddiqui A, Morrison GA, D'Cruz DP. Morbidity and mortality associated with subglottic laryngotracheal stenosis in granulomatosis with polyangiitis (Wegener's granulomatosis): a single-centre experience in the United Kingdom. J Laryngol Otol 2014;128:831-7. [PMID: 25180544 DOI: 10.1017/S0022215114001650] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
26 Sharma A, Gopalakrishan D, Nada R, Kumar S, Dogra S, Aggarwal MM, Gupta R, Minz RW, Kakkar N, Vashishtha RK, Singh S. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades. Int J Rheum Dis 2014;17:562-72. [PMID: 24237487 DOI: 10.1111/1756-185X.12223] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
27 Yuan S, Lian F, Chen D, Li H, Qiu Q, Zhan Z, Ye Y, Xu H, Liang L, Yang X. Clinical Features and Associated Factors of Abdominal Pain in Systemic Lupus Erythematosus. J Rheumatol 2013;40:2015-22. [DOI: 10.3899/jrheum.130492] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
28 Shovman O, Langevitz P, Gilburd B, Shoenfeld Y. Coincidence of granulomatosis and polyangiitis with atypical clinical manifestation and antiphospholipid syndrome. Lupus 2013;22:320-3. [PMID: 23439472 DOI: 10.1177/0961203313475692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
29 Paroli M, Polidoro A, Romano S, Accapezzato D. Churg-Strauss syndrome associated with antiphospholipid antibodies in a patient with recurrent myocardial and cerebral ischemia. Int Med Case Rep J 2012;5:79-81. [PMID: 23754929 DOI: 10.2147/IMCRJ.S37516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
30 Caldas CA, de Carvalho JF. Antiphospholipid syndrome and polyarteritis nodosa: a diagnostic and therapeutic challenge. Rheumatol Int 2013;33:2697-8. [PMID: 22833243 DOI: 10.1007/s00296-012-2495-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
31 Wlodek C, Robson MG. Anti-neutrophil cytoplasmic antibody vasculitis presenting with bilateral renal vein thrombosis. Clin Kidney J 2012;5:229-31. [PMID: 26069771 DOI: 10.1093/ckj/sfs021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
32 Alkayed K, Kottke-Marchant K. Indeterminate lupus anticoagulant results: Prevalence and clinical significance. Korean J Hematol 2011;46:239-43. [PMID: 22259629 DOI: 10.5045/kjh.2011.46.4.239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Vece TJ, de Guzman MM, Langston C, Fan LL. Diffuse Alveolar Hemorrhage in Children. Kendig & Chernick’s Disorders of the Respiratory Tract in Children. Elsevier; 2012. pp. 848-57. [DOI: 10.1016/b978-1-4377-1984-0.00058-9] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
34 Wiik AS. Autoantibodies in ANCA-associated Vasculitis. Rheumatic Disease Clinics of North America 2010;36:479-89. [DOI: 10.1016/j.rdc.2010.05.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
35 Santos MS, de Carvalho JF, Brotto M, Bonfa E, Rocha FA. Peripheral neuropathy in patients with primary antiphospholipid (Hughes') syndrome. Lupus 2010;19:583-90. [PMID: 20156929 DOI: 10.1177/0961203309354541] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
36 Đorđević V, Zvezdanović L, Ćosić V, Vlahović P, Kundalić S, Jevtović-stoimenov T, Stamenković B, Mitrović D. Serum Levels and in Vitro Production of Th1- and Th2-Type Cytokines by Peripheral Blood Mononuclear Cells in Patients Suffering from Systemic Lupus Erythematosus. Journal of Medical Biochemistry 2010;29:19-27. [DOI: 10.2478/v10011-010-0005-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Ju JH, Min JK, Jung CK, Oh SN, Kwok SK, Kang KY, Park KS, Ko HJ, Yoon CH, Park SH. Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE. Nat Rev Rheumatol. 2009;5:273-281. [PMID: 19412194 DOI: 10.1038/nrrheum.2009.53] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 6.9] [Reference Citation Analysis]
38 Trifiletti A, Scamardi R, Bagnato GF, Gaudio A. Hemostatic changes in vasculitides. Thromb Res 2009;124:252-5. [PMID: 19525001 DOI: 10.1016/j.thromres.2009.05.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
39 Asherson RA, Bucciarelli S, Gómez-puerta JA, Cervera R. Chapter 1 History, Classification, and Subsets of the Antiphospholipid Syndrome. Handbook of Systemic Autoimmune Diseases 2009. [DOI: 10.1016/s1571-5078(08)00401-7] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
40 Fonseca AG, D'Cruz DP. Controversies in the antiphospholipid syndrome: can we ever stop warfarin? J Autoimmune Dis 2008;5:6. [PMID: 19014462 DOI: 10.1186/1740-2557-5-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
41 Carvalho JF. Some concerns about the Sydney criteria for antiphospholipid syndrome. Lupus 2008;17:770. [PMID: 18625658 DOI: 10.1177/0961203308093459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
42 Taylor PC. The future of TNF-α antagonism. Future Rheumatology 2007;2:233-6. [DOI: 10.2217/17460816.2.3.233] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
43 Bagnasco M, Grassia L, Pesce G. The management of the patient with unexpected autoantibody positivity. Autoimmunity Reviews 2007;6:347-53. [DOI: 10.1016/j.autrev.2007.01.011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
44 Carlson JA, Chen K. Cutaneous Pseudovasculitis. The American Journal of Dermatopathology 2007;29:44-55. [DOI: 10.1097/01.dad.0000245195.35106.3c] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 5.3] [Reference Citation Analysis]
45 Ferenczi K, Chang T, Camouse M, Han R, Stern R, Willis J, Cooper KD, Gilliam AC. A case of Churg-Strauss syndrome associated with antiphospholipid antibodies. J Am Acad Dermatol 2007;56:701-4. [PMID: 17175066 DOI: 10.1016/j.jaad.2006.09.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
46 . Bibliography. Current world literature. Vasculitis syndromes. Curr Opin Rheumatol 2007;19:81-5. [PMID: 17143101 DOI: 10.1097/BOR.0b013e32801437a8] [Reference Citation Analysis]
47 Carlson JA, Chen K. Cutaneous Vasculitis Update: Small Vessel Neutrophilic Vasculitis Syndromes. The American Journal of Dermatopathology 2006;28:486-506. [DOI: 10.1097/01.dad.0000246646.45651.a2] [Cited by in Crossref: 139] [Cited by in F6Publishing: 146] [Article Influence: 8.2] [Reference Citation Analysis]
48 Carlson JA, Cavaliere LF, Grant-kels JM. Cutaneous vasculitis: diagnosis and management. Clinics in Dermatology 2006;24:414-29. [DOI: 10.1016/j.clindermatol.2006.07.007] [Cited by in Crossref: 101] [Cited by in F6Publishing: 108] [Article Influence: 5.9] [Reference Citation Analysis]
49 Foster R, Rosenthal E, Marques S, Vounotrypidis P, Sangle S, D’cruz D. Primary systemic vasculitis: treatment of difficult cases. Lupus 2006;15:143-147. [DOI: 10.1191/0961203306lu2277rr] [Reference Citation Analysis]